Recent studies have shown that modafinil improves cognitive abilities in healthy, non-sleep-deprived individuals. These improvements are associated with higher-level cognitive processes such as decision-making and planning.
Modafinil 200 Australia significantly improved digit span, visual pattern recognition memory, spatial planning and response inhibition in both healthy volunteers and ADHD patients. It also improved performance on the complex IDED shift task, including a slowing of response latency.
Improved Memory and Learning
Modafinil improves cognitive performance in healthy non-sleep deprived people. Specifically, Modafinil enhances memory and learning in complex thought processes that involve decision-making and planning. It also improves arithmetic and perceptual tasks that require cognitive control.
In a placebo-controlled single-dose study of 20 adult ADHD patients, 200 mg of modafinil was associated with significant enhancements in performance on delayed match-to-sample, Tower of London and spatial planning tasks relative to placebo. This performance enhancement was complemented by slowed latencies on the Delayed Match-to-Sample and Spatial Planning tasks, indicating that modafinil improved working memory capacity, inhibited pre-potent responding and increased attentional set-shifting – a task strongly dependent in humans on ascending DA systems (Turner et al, 2004a).
Similarly, a placebo-controlled study of medication-free narcolepsy patients found that modafinil enhanced memory and learning, but not arithmetic or perceptual skills, as measured with the Pauli Test. This finding was accompanied by improved EEG responses in the frontal and anterior cingulate cortices.
Modafinil is also known to improve learning in animals. For example, modafinil enhances working memory performance in a dose and delay-dependent manner on the sequential alternation task in mice, while not altering exploratory or anxiety-related activity (Beracochea et al, 2001). This improvement is also accompanied by reduced latency in the incongruent condition of the Stroop test, a measure of lateralization of response inhibition.
Increased Focus
Modalert 200 mg, a wake-promoting agent developed for narcolepsy, has also been widely used off-label as a cognitive enhancer. In studies of sleep-deprived volunteers, modafinil has shown strong benefits in many neuropsychological tasks, but less is known about its effects on healthy individuals under normal conditions. This study aimed to evaluate the cognitive enhancing potential of this novel agent using a battery of demanding tasks.
Healthy, non-sleep-deprived college students received either 200 mg modafinil or placebo. Subjects performed on a series of demanding tasks that tax components of attention shifting, prospective memory, and working memory. Modafinil improved accuracy without a trade-off in both attention-shifting conditions and in a task that required disengagement from one ongoing task to retrieve and act upon a previously formed intention. However, it did not improve performance in a simple arithmetic task or in the digit span or BCET tests. Modafinil shortened response latency in the incongruent situation of the Stroop test, a measure of prefrontal inhibition.
These findings suggest that modafinil may selectively improve neuropsychological task performance by increasing the ability to inhibit pre-potent responses and reduce impulsive responding, thereby improving the ability to shift attention when resources are most challenged. These effects might be especially relevant in schizophrenia, where the ED stage of the attentional set shifting task is frequently impaired (Pantelis and Brewer, 1995). Young community-based patients with schizophrenia display high levels of perseveration at this stage, suggesting that their difficulty with attentional set shifting might be related to an inability to inhibit responses to irrelevant dimensions.
Increased Energy
Modafinil has also been shown to improve memory consolidation, which is a process that occurs when new information is stabilized and stored in long-term memory. It has also been found to increase working memory, which is the cognitive system that holds and manipulates information. This may allow for improved multitasking and increased capacity for learning.
A number of studies have found that modafinil enhances performance on tests of attention, vigilance and working memory in healthy sleep-deprived individuals. These effects appear to be due to the drug’s primary actions on catecholaminergic systems, including dopamine and norepinephrine.
It is believed that these effects are due to modulation of the dopamine transporter, which reduces the amount of dopamine that leaves brain cells after it has been used for motivation or reward. This reduces the likelihood of the brain making errors in response to unrewarded stimuli and also helps prevent impulsive behavior.
Modafinil is a commonly prescribed treatment for conditions such as narcolepsy and shift work sleep disorder. It is also known to improve the ability of individuals with obstructive sleep apnea to stay awake during the day, helping them to perform better at work and improve their overall quality of life. The drug has also been found to be effective in reducing symptoms of depression and ADHD, although more research is needed.
Reduced Insomnia
Modafinil reduces daytime sleepiness in people with sleep disorders. It also reduces the need for sleep at night and improves wakefulness in narcoleptic patients. It is safer than stimulants and has fewer side effects. However, it does have a risk for developing mania in some people.
A placebo-controlled study of modafinil in narcoleptics showed that it reduced both nocturnal sleep and the number of times narcoleptics awakened during the night. It also improved wakefulness in the morning and improved performance on a test of alertness. The effect was greater in narcoleptics with the most severe insomnia, but the study did not show a clinically meaningful improvement in symptoms of narcolepsy.
Modafinil significantly enhanced performance on tests of digit span, visual pattern recognition memory, and spatial planning. In addition, it slowed response latency on the stop-signal reaction task. However, it did not improve paired associates learning or attentional set shifting. In contrast, methylphenidate had no significant effects on these tasks.
It is important to talk to your healthcare provider before taking modafinil. Discuss your medical history and current medications, including over-the-counter drugs and herbal supplements. You should not take modafinil if you have heart problems, high blood pressure, liver or kidney disease, or a history of mental health disorders. You should not drive or operate machinery until you know how modafinil affects you.
Leave a Reply